Professional Documents
Culture Documents
GLOMERULONEFRITIS
AKUT (GNA)
GLOMERULONEFRITIS AKUT
PASCA STREPTOKOKKUS
(GNAPS)
1. Angka kejadian
Lebih sering umur 6-7 thn, jarang < 3 thn
Laki laki > perempuan (2:1)
10- 12 % kasus infeksi strept. hemolitikus
grup A
Kaplan: 50% kasus asimtomatik pd epidemi
GNAPS didahului ISPA atau piodermi
2. Etiologi
Streptokokus hemolitikus grup A (tipe M)
NEFRITOGENIK
Faringitis (serotipe tersering 12, lalu 1,3,4,6,25)
Piodermi (serotipe tersering 49, lalu 2,53,55,
56,57,58,60
MANIFESTASI KLINIK
a. Periode latent: 1 3 minggu
b. Edema
c. Hematuri
d. Hipertensi
e. Oligouria
f. Gejala-gejala lain: lelah, malaise, letargi
& anoreksia
g. Kelainan laboratorium
URIN:
Hematuri, warna kemerah-merahan atau
seperti air daging
Proteinuri : kualitatif dan kuantitatif
> 6 bulan
proteinuri persisten
biopsi ginjal
DARAH:
Titer ASTO meningkat
Menurunnya kadar C3
LED meninggi
Hipoproteinemi ringan
Pemeriksaan bakteriologik
Diagnosis GNAPS
Bila memenuhi 4 gejala berikut
Hematuri makroskopik atau mikroskopik
Edema
Hipertensi
ASTO meningkat
C3 menurun
1. Edema Masif
2. Proteinuri Masif
3. Hipoproteinemi (< 2,5 g/dl)
4. Hiperkolesterolemi
(>250 mg/dl)
ANGKA KEJADIAN
Anak > dewasa
Anak: 1 3 tahun
> 5 tahun
Wila Wirya (1992): 6 kasus/100.000 penduduk
< 14 thn/thn
ETIOLOGI
Tidak diketahui: SN idiopatik
Genetik
: SN kongenital
HLA-B12, HLA B8
PATOMEKANISME
Soluble antigen- antibody complex
Teori elektrokemik
DEFINITION
Significant bacteriuria
Pathogenic bacteria
Colony count : > 100.000/ml urine
> 1x lab. examinations
Relapsing UTI :
Recurrent UTI
Same microorganism
Reinfection UTI :
Recurrent UTI
Different microrganism
ETIOLOGY
Bacteria :
E. Coli
Klebsiella
Proteus
Pseudomonas
Other microorganisms :
Protozoa
Virus
CLASSIFICATION
PATHOGENESIS
1. Hematogenic
2. Percontinuitatum
3. Lymphogenic
DIAGNOSIS
Clinically :
1. Upper UTI (Pyelonephritis) :
Fever, back/flank pain & with or
without lower UTI symptoms
2. Lower UTI (Cystitis) :
Suprapubic punction, dysuria,
frequent voiding etc.
PATHOGENESIS
Neonates
Colonization on GIT
Certain focus
Hematogen
(Septicemia)
Percontinuitatum
(Ascending)
: Periurethra/Perineum
: Subpreputium
?
Bacteria enter to
Urinary tract
Symptomatic UTI
Asymptomatic UTI
LAB. EXAMINATIONS
URINE :
1. Urinalysis :
2. Urine culture :
a. Mid : stream urine :
C.C. : > 100.000/ml urine
b. Catheterization :
C.C. : > 10.000/ml urine
c. Suprapubic punction :
C.C. : > 1000/ml urine
BLOOD :
Leucocytosis
Increased BSR (> 30 mm/hour)
Increased CRP (> 30 ug/ml)
MANAGEMENT
ETIOLOGY:
A. Prerenal: Decrased blood flow
Diarrhea dehydration
Hemorrhage
Burns
Septic shock
B. Renal:
Acute Tubular Necrosis
Acute Nephritic Syndrome
Nephrotic syndrome
Acute Pyelonephritis
2. Renal :
Acute Tubular Necrosis (perinatal asphyxia)
Maternal-fetal transfer:
Antibodies
Infections: syphilis, Cytomegalovirus
CLINICAL MANIFESTATIONS:
1. Decreased urine volume (Oligouria Anuria)
2. Generalized swelling
3. Changes in mental status:
Unconscious
Delirium/confusion
Coma
4. Seizures
5. Nausea, vomiting
6. Anemia
7. Kusmaul respiration
DIAGNOSIS
Clinical Manifestations
Lab. Examination:
Serum Ureum increased
Serum Creatinin increased
Creatinin Clearance
Serrum Potasium
TREATMENT
1.
2.
Medical drugs:
Antibiotics: To prevent infection
Diuretics: to treat oligouria or anuria
Diazepam: To handle convulsion
3. Emergency condition:
Hyperkalemia:
Ca Glukonas
Potassium exchange resin
(Kayexalate) Oral/rectal
Metabolic acidosis: Bicarbonate Natricus
ETIOLOGY:
< 5 years old:
Hypoplasia / Dysplasia kidney
Congenital structure of urinary tract
Vesicoureteral reflux
Congenital Nephrotic Syndrome
5 15 years old :
Hereditary diseases: Alports syndrome,
sistinuri
Primary glomerulonephritis: Nephritic
Syndrome
Secondary glomerulonephritis : SLE,SHS
TREATMENT
1.
Conservative Treatment:
The aims of this treatment:
Preparing the child & family for the
treatment of CRF
Slowly progression to End Stage RF
2. Replacement therapy:
The aims is to replace the function of the
unfunction kidney by:
Dialysis:
Peritoneal dialysis (PD)
Hemodialysis
Transplantation
Complication of SLE
Damage to glomerulus
Progressive loss of kidney function
ETIOLOGY :
1. Unknown
2. Genetic factor :
HLA Antigen (HLA-DR2, HLA-DR3)
High incidence in monozygotic twin
High incidence in family
3. Nongenetic factor:
Longterm treatment of certain drugs
(>6 months) hydralazine
Sex hormone: estrogen SLE (>)
Viral infection
Joints
Heart
Lungs
Blood vessels
Kidneys
Skin
PATHOGENESIS
Autoimune process
MBG
Renal symptoms
GENERAL SYMPTOMS
Fever
Malar rash:
CLINICAL MANIFESTATIONS:
RENAL SYMTOMPS
1. PROTEINURIA:
(+)(++) (30-100 mg/dl)
Haematuria (+)/(-)
2. ACUTE NEPHRITIC SYNDROME
3. NEPHROTIC SYNDROME
DIAGNOSIS
Clinical Manifestations
Lab. Examination:
Blood:
CLASIFICATION HISTOPATHOLOGIC
I.
II.
Mesangial Glomerulonephritis
Membranous Glomerulonephritis
TREATMENT
Class I & II :
Symptomatic treatment
No specific treatment
Class III,IV&V:
Symptomatic treatment
Specific treatment
Corticosteroid
Immunosuppressive
KIDNEY :
1. AGENESIS : BILATERAL RENAL AGENESIS
= Potters Syndrome
Oligohydramnion
Pulmonary hypoplasia
Low-set ears
2. RENAL HYPOPLASIA :
3. Horseshoe kidney :
Fusion of the renal parenchyma
Joined at the lower pole
4. Polycystic kidney :
a. Infantile Polycystic Kidney (IPCK)
b. Adults Polycystic Kidney (APCK)
IPCK
Autosomal Recessive Polycystic Kidney
Enlargement of distal tubulus & colligents
ductus
Glomerulus & proximal tubulus normal
Liver enlargement
URETER
Duplication of ureter
Ureterocele
Ectopic ureter
URETHRA
Agnesia / atresia urethra
Congenital posterior urethral valves
SHS :
Systemic disease
Vasculitis on :
Skin purpura
Joint arthritis
Digestive tract abdominal pain
Kidney glomerulonephritis
INCIDENCE
Age incidence :
All ages
75% of cases : 2-11 years
Sex incidence : : = 2 : 1
50% of cases : preceded by upper respiratory
infection group A streptococci
CLINICAL MANIFESTATIONS
1. PURPURA :
Erythematous macular palpable purpura
Ecchymotic
Associated with subcutaneous edema
(extremities, scalp, periorbital region,
hands, feet, scrotal area)
Lower legs, ankles, dorsal foot ( symmetric)
2. Gastrointestinal Symptoms:
Abdominal pain : 35-85% of cases
Gastrointestinal bleeding: melena,
hematemesis, bloody stool
Invagination, intestinal perforation
3. Joint Symptoms:
Arthritis
Arthralgia
Ankles & knees: most commonly
affected
The three signs: Classic triad of SHS
PATHOPHYSIOLOGY
INCITING FACTOR (URIStreptococcus)
Activate complement
Renal symptoms
MANAGEMENT
1. Self Limiting Disease
2. Supportive & symptomatic Treatment:
Fluid intake
Antihypertensive Hypertensive patient
Diuretic Oligouria
Antibiotic Infection
Analgesics Arthralgia
3. Specific treatment:
Corticosteroid (Prednison 1-2 mg/kgBW)
Severe Abdominal pain
GI bleeding
Renal treatment
R/ Acute Nephritic syndrome
Nephrotic Syndrome
Renal Failure